144 related articles for article (PubMed ID: 17254320)
1. FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders.
Chiappetta G; Ferraro A; Botti G; Monaco M; Pasquinelli R; Vuttariello E; Arnaldi L; Di Bonito M; D'Aiuto G; Pierantoni GM; Fusco A
BMC Cancer; 2007 Jan; 7():17. PubMed ID: 17254320
[TBL] [Abstract][Full Text] [Related]
2. FRA-1 expression in hyperplastic and neoplastic thyroid diseases.
Chiappetta G; Tallini G; De Biasio MC; Pentimalli F; de Nigris F; Losito S; Fedele M; Battista S; Verde P; Santoro M; Fusco A
Clin Cancer Res; 2000 Nov; 6(11):4300-6. PubMed ID: 11106247
[TBL] [Abstract][Full Text] [Related]
3. An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy.
Song Y; Song S; Zhang D; Zhang Y; Chen L; Qian L; Shi M; Zhao H; Jiang Z; Guo N
BMC Cancer; 2006 Dec; 6():298. PubMed ID: 17192200
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Fos-related antigen-1 in head and neck squamous cell carcinoma.
Mangone FR; Brentani MM; Nonogaki S; Begnami MD; Campos AH; Walder F; Carvalho MB; Soares FA; Torloni H; Kowalski LP; Federico MH
Int J Exp Pathol; 2005 Aug; 86(4):205-12. PubMed ID: 16045542
[TBL] [Abstract][Full Text] [Related]
5. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM
Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566
[TBL] [Abstract][Full Text] [Related]
6. Expression and distribution of AP-1 transcription factors in the porcine ovary.
Rusovici R; LaVoie HA
Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma.
Zhu XL; Hartwick W; Rohan T; Kandel R
Mod Pathol; 1998 Nov; 11(11):1082-8. PubMed ID: 9831206
[TBL] [Abstract][Full Text] [Related]
8. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.
Belguise K; Kersual N; Galtier F; Chalbos D
Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675
[TBL] [Abstract][Full Text] [Related]
9. Comparison of extracellular matrix and apoptotic markers between benign lesions and carcinomas in human breast.
Vasaturo F; Sallusti E; Gradilone A; Malacrino C; Nardo T; Avagnano G; Aglianò AM; Granato T; De Vincenzi B; Coppotelli G; Marzullo A; Soda G; Simonelli L; Modesti M; Scarpa S
Int J Oncol; 2005 Oct; 27(4):1005-11. PubMed ID: 16142317
[TBL] [Abstract][Full Text] [Related]
10. Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.
Zhang L; Pan HY; Zhong LP; Wei KJ; Yang X; Li J; Shen GF; Zhang Z
J Oral Pathol Med; 2010 Jul; 39(6):470-6. PubMed ID: 20149058
[TBL] [Abstract][Full Text] [Related]
11. Sleep research in space: expression of immediate early genes in forebrain structures of rats during the nasa neurolab mission (STS-90).
Centini C; Pompeiano O
Arch Ital Biol; 2007 May; 145(2):117-50. PubMed ID: 17639784
[TBL] [Abstract][Full Text] [Related]
12. Fos-related antigen 1 modulates malignant features of glioma cells.
Debinski W; Gibo DM
Mol Cancer Res; 2005 Apr; 3(4):237-49. PubMed ID: 15831677
[TBL] [Abstract][Full Text] [Related]
13. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product.
Vallone D; Battista S; Pierantoni GM; Fedele M; Casalino L; Santoro M; Viglietto G; Fusco A; Verde P
EMBO J; 1997 Sep; 16(17):5310-21. PubMed ID: 9311991
[TBL] [Abstract][Full Text] [Related]
14. DMBT1 expression is down-regulated in breast cancer.
Braidotti P; Nuciforo PG; Mollenhauer J; Poustka A; Pellegrini C; Moro A; Bulfamante G; Coggi G; Bosari S; Pietra GG
BMC Cancer; 2004 Aug; 4():46. PubMed ID: 15301691
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific expression of the fos-related transcription factor fra-2 during mouse development.
Carrasco D; Bravo R
Oncogene; 1995 Mar; 10(6):1069-79. PubMed ID: 7700631
[TBL] [Abstract][Full Text] [Related]
16. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
Tuszynski GP; Nicosia RF
Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
Pechoux C; Chardonnet Y; Chignol MC; Noël P
Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue.
Spandidos DA; Pintzas A; Kakkanas A; Yiagnisis M; Mahera H; Patra E; Agnantis NJ
Anticancer Res; 1987; 7(6):1299-304. PubMed ID: 3327455
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms.
Zhang W; Hart J; McLeod HL; Wang HL
Am J Clin Pathol; 2005 Jul; 124(1):11-9. PubMed ID: 15923159
[TBL] [Abstract][Full Text] [Related]
20. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
